OMC vs PMCB · rev $17.27B vs $8.6M cap
Omnicom Group Inc (OMC) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Omnicom Group Inc (OMC) is a advertising agencies company listed on NYSE.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported OMC revenue for 2025-12-31 was $17.27B. Net income was -$54.5M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. OMC currently screens at market cap $21.75B.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
OMC currently screens at market cap $21.75B. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the OMC and PMCB stock pages for the full models.
Not investment advice.